Legend Biotech (LEGN) Income towards Parent Company (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Income towards Parent Company data on file, last reported at -$55.0 million in Q1 2026.

• Quarterly Income towards Parent Company rose 45.5% year-over-year to -$55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$248.6 million (down 1.7% YoY) and the FY2025 annual result came in at -$296.8 million, down 167558.99% from the prior year.
• Income towards Parent Company fell to -$55.0 million in Q1 2026, from -$30.9 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $26284.0 in Q4 2024 to a low of -$199.1 million in Q2 2023.
• A 5-year average of -$80.7 million and a median of -$62.2 million in 2023 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2024 — Income towards Parent Company soared 118.15% — and 2025, when it plunged 117662.01%.
• Tracing LEGN's Income towards Parent Company over 5 years: stood at -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then jumped by 118.15% to $26284.0 in 2024, then sank by 117662.01% to -$30.9 million in 2025, then plunged by 77.99% to -$55.0 million in 2026.
• The last three Income towards Parent Company figures came in at -$55.0 million (Q1 2026), -$30.9 million (Q4 2025), and -$38.5 million (Q3 2025), per Business Quant data.